Making the Way for Innovation

(W2) AMCP Partner Session: Case Studies of How Prescription Digital Therapeutics Help Payers Achieve the Quadruple Aim

Tuesday, October 20, 2020

3:00pm – 4:00pm

ACPE UAN: N/A | Contact Hours: N/A | Activity Type:
N/A

Faculty(s)

Katie Archer

Director, Health and Welfare Plans Benefits Design, Planning and Analysis
The Hartford Financial Services Group, Inc.
Hartford, Connecticut
Yuri Maricich, MD

Chief Medical Officer and Head of Development
Pear Therapeutics
Boston, Massachusetts
Fulton Velez, MD, MS, MBA

Head Health Economics and Real-World Evidence
Pear Therapeutics
Boston, Massachusetts
Renee Wallace, PharmD

Clinical Pharmacist
Serve You Rx
Milwaukee, Wisconsin

Moderator(s)

Mike Pace

Head of Market Access, Value and Evidence
Pear Therapeutics
Boston, Massachusetts

Please Note: This session was developed by Pear Therapeutics, Inc. and is not accredited for continuing pharmacy education credit.

Digital therapeutics are all the buzz, but how can managed care pharmacy leaders turn this talk into improved patient satisfaction, better health outcomes, enhanced provider experience, and reduced costs?

During this panel discussion, leaders of three innovative organizations will discuss:
• What prescription digital therapeutics (PDTs) are and how they support and advance managed care pharmacy, featuring
real-world evidence about how they engage patients, impact key clinical endpoints, enhance provider-patient interaction, and help to reduce costs.
• How a large employer and a PBM assessed, implemented into standard benefits, and now manage these novel therapies.
• What PDTs are emerging and how they will complement care pathways and lead to better access and health.

Learning Objectives: :

At the completion of this activity, participants should be able to:

Describe the potential benefits of prescription digital therapeutics (PDTs) to their organization.
Discuss the potential impact PDTs can have on patients, network providers, and plan sponsors.
Summarize how coverage of PDTs can occur within standard benefit design.